Senator Richard Blumenthal from Connecticut is speaking out against pharmaceutical companies for abusing the patent system and driving up the cost of prescription drugs. He argues that these companies use tactics to prevent lower-priced drugs from entering the market, causing the average cost of a prescription drug to increase significantly over the past few years. Nora Duncan from the AARP supports Blumenthal’s claims, stating that these practices are costing Americans millions of dollars.
Recently, the U.S. Department of Health and Human Services announced reductions in the cost of 54 drugs for Medicare Part B enrollees. This measure received unanimous support in the senate, but is expected to face resistance from the legal and lobbying teams of pharmaceutical companies.
Blumenthal is determined to address the issue of patent abuse by pharmaceutical companies and ensure that Americans have access to more affordable prescription drugs. By challenging these companies and their tactics, he hopes to bring about change and reduce the financial burden on individuals seeking necessary medications. The fight against rising prescription drug costs continues as lawmakers work towards a solution that benefits consumers and puts an end to these harmful practices.
Source
Photo credit www.wtnh.com